CD8A and neoplasm: There was a strong and significant correlation between tumor size and Treg tumor levels and tumor size and CD8 + to Treg ratios when combining GPB730 with anti-CTLA-4, which was not observed in anti-CTLA-4-treated mice (Fig. 5c).